Abstract
BackgroundOvarian and endometrial cancers are commonly occurring cancers in women with very limited treatment options for relapse and metastasis. While immune checkpoint inhibitors have generated unprecedented responses in certain other...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
